Rationale, Mission and Vision for a National Centre of Affective
                    Disorders in Germany

Andreas Reif; Bernhard T. Baune; Jürgen Deckert; Georg Juckel; Sarah Kittel-Schneider; Tilo Kircher; Johannes Kornhuber; Rainer Rupprecht; Michael Bauer

doi:10.1055/a-1697-5854

Pharmacopsychiatry, Inhaltsverzeichnis

Pharmacopsychiatry 2022; 55(02): 65-72
DOI: 10.1055/a-1697-5854

Review

Rationale, Mission and Vision for a National Centre of Affective Disorders in Germany

Andreas Reif

¹Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt – Goethe University, Frankfurt am Main, Germany

,

Bernhard T. Baune

²Department of Psychiatry, University Hospital Münster, University of Münster, Münster, Germany

,

Jürgen Deckert

³Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany

,

Georg Juckel

⁴Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr University Bochum, Germany

,

Sarah Kittel-Schneider

³Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany

,

Tilo Kircher

⁵Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany

,

Johannes Kornhuber

⁶Department of Psychiatry and Psychotherapy, University Hospital Erlangen, Friedrich-Alexander-University of Erlangen-Nuremberg, Germany

,

Rainer Rupprecht

⁷Department of Psychiatry and Psychotherapy, University Regensburg, Regensburg, Germany

,

Michael Bauer

⁸Department of Psychiatry and Psychotherapy, Medical Faculty, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany

› Institutsangaben

Abstract

Affective disorders are common, complex disorders representing one of the major challenges to global health in the 21st century. To mitigate the burden of disease, substantial public health efforts need to be undertaken since research on the causes and adequate treatment requires multidisciplinary approaches. These should integrate translational, and clinical research, aided by technological advancements in collecting and analysing comprehensive data. Here we present the rationale, concept, mission and vision of the recently founded National Centre of Affective Disorders (NCAD) in Germany. NCAD founding partners build on their previous successful cooperation within the German Research Network for Mental Disorders funded by the Federal Ministry of Education and Research (BMBF). They form an internationally pre-eminent network of integrative excellence, leading in science and contributing significantly to the improved care of affective disorder patients. The partners will provide complementary structures and innovative methods across the entire translational continuum from bench to clinical and real-world settings. The vision of the NCAD is to foster cross-disciplinary research from basic neuroscience to public mental health by close translational collaboration between academia, non-university research institutions, and international partners, including industry, to deliver cutting-edge research, innovative clinical services and evidence-based training to young clinicians and scientists. The mission is to accomplish research in a highly translational manner, especially with respect to clinical studies in a trans-sectoral way. This approach aims to ensure continuous improvement in the treatment and care provided to patients and an interdisciplinary environment for high-level research and education in affective disorders.

Key words

affective disorders - bipolar disorder - major depression - anxiety - network

Volltext

Referenzen

References
1 Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry 2015; 76: 155-162
2 Johnston KM, Powell LC, Anderson IM, Szabo S, Cline S. The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature. J Affect Disord 2019; 242: 195-210
3 Bessonova L, Ogden K, Doane MJ, O'Sullivan AK, Tohen M. The economic burden of bipolar disorder in the United States: A systematic literature review. Clinicoecon Outcomes Res 2020; 12: 481-497
4 Wittchen HU, Jacobi F, Rehm J. et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655-679
5 Konnopka A, Konig H. Economic burden of anxiety disorders: A systematic review and meta-analysis. Pharmacoeconomics 2020; 38: 25-37
6 Angst J, Azorin JM, Bowden CL. et al. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: The BRIDGE study. Arch Gen Psychiatry 2011; 68: 791-798
7 Pelletier L, O'Donnell S, Dykxhoorn J, McRae L, Patten SB. Under-diagnosis of mood disorders in Canada. Epidemiol Psychiatr Sci 2017; 26: 414-423
8 Gogos A, Ney LJ, Seymour N, Van Rheenen TE, Felmingham KL. Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link?. Br J Pharmacol 2019; 176: 4119-4135
9 Hayes JF, Marston L, Walters K, King MB, Osborn DPJ. Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014. Br J Psychiatry 2017; 211: 175-181
10 Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Is excess mortality higher in depressed men than in depressed women? A meta-analytic comparison. J Affect Disord 2014; 161: 47-54
11 Philpott LF, Savage E, FitzGerald S, Leahy-Warren P. Anxiety in fathers in the perinatal period: A systematic review. Midwifery 2019; 76: 54-101
12 Edward KL, Castle D, Mills C, Davis L, Casey J. An integrative review of paternal depression. Am J Mens Health 2015; 9: 26-34
13 Bobo WV, Yawn BP. Concise review for physicians and other clinicians: Postpartum depression. Mayo Clin Proc 2014; 89: 835-844
14 Schubert KO, Clark SR, Van LK, Collinson JL, Baune BT. Depressive symptom trajectories in late adolescence and early adulthood: A systematic review. Aust N Z J Psychiatry 2017; 51: 477-499
15 Kaltenboeck A, Harmer C. The neuroscience of depressive disorders: A brief review of the past and some considerations about the future. Brain Neurosci Adv 2018; 2: 2398212818799269
16 Kloiber S, Rosenblat JD, Husain MI. et al. Neurodevelopmental pathways in bipolar disorder. Neurosci Biobehav Rev 2020; 112: 213-226
17 Davidson JR. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 2010; 71: e04
18 Kishi T, Ikuta T, Matsuda Y. et al. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: A systematic review and network meta-analysis of randomized controlled trials. Mol Psychiatry 2021; 26: 4146-4157
19 Papakostas GI, Salloum NC, Hock RS. et al. Efficacy of Esketamine augmentation in major depressive disorder: A meta-analysis. J Clin Psychiatry 2020; 81: 19r12889
20 Galvao-Coelho NL, Marx W, Gonzalez M. et al. Classic serotonergic psychedelics for mood and depressive symptoms: A meta-analysis of mood disorder patients and healthy participants. Psychopharmacology (Berl) 2021; 238: 341-354
21 Razza LB, Palumbo P, Moffa AH. et al. A systematic review and meta-analysis on the effects of transcranial direct current stimulation in depressive episodes. Depress Anxiety 2020; 37: 594-608
22 Group UER. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet 2003; 361: 799-808
23 Mutz J, Vipulananthan V, Carter B. et al. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: Systematic review and network meta-analysis. BMJ 2019; 364: l1079
24 Lovas DA, Schuman-Olivier Z. Mindfulness-based cognitive therapy for bipolar disorder: A systematic review. J Affect Disord 2018; 240: 247-261
25 van Bronswijk S, Moopen N, Beijers L. et al. Effectiveness of psychotherapy for treatment-resistant depression: a meta-analysis and meta-regression. Psychol Med 2019; 49: 366-379
26 Konig IR, Fuchs O, Hansen G. et al. What is precision medicine?. Eur Respir J 2017; 50: 1700391
27 Lu YF, Goldstein DB, Angrist M. et al. Personalized medicine and human genetic diversity. Cold Spring Harb Perspect Med 2014; 4: a008581
28 Cuthbert BN, Insel TR. Toward new approaches to psychotic disorders: The NIMH Research Domain Criteria project. Schizophr Bull 2010; 36: 1061-1062
29 Rosenblat JD, Kakar R, Berk M. et al. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disord 2016; 18: 89-101
30 Kohler-Forsberg O, NL C, Hjorthoj C. et al. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: Meta-analysis of clinical trials. Acta Psychiatr Scand 2019; 139: 404-419
31 Ludwig B, Dwivedi Y. Dissecting bipolar disorder complexity through epigenomic approach. Mol Psychiatry 2016; 21: 1490-1498
32 Matosin N, Halldorsdottir T, Binder EB. Understanding the molecular mechanisms underpinning gene by environment interactions in psychiatric disorders: The FKBP5 model. Biol Psychiatry 2018; 83: 821-830
33 Weintraub MJ, Schneck CD, Axelson DA. et al. Classifying mood symptom trajectories in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2020; 59: 381-390
34 Scott K, Lewis CC, Marti CN. Trajectories of symptom change in the treatment for adolescents with depression study. J Am Acad Child Adolesc Psychiatry 2019; 58: 319-328
35 Shaw P, Sudre G. Adolescent attention-deficit/hyperactivity disorder: Understanding teenage symptom trajectories. Biol Psychiatry 2021; 89: 152-161
36 Faedda GL, Serra G, Marangoni C. et al. Clinical risk factors for bipolar disorders: A systematic review of prospective studies. J Affect Disord 2014; 168: 314-321
37 Franke B, Michelini G, Asherson P. et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol 2018; 28: 1059-1088
38 Remes O, Brayne C, van der Linde R. et al. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav 2016; 6: e00497
39 Gross-Lesch S, Dempfle A, Reichert S. et al. Sex- and subtype-related differences in the comorbidity of adult ADHDs. J Atten Disord 2016; 20: 866
40 Melton TH, Croarkin PE, Strawn JR. et al. Comorbid anxiety and depressive symptoms in children and adolescents: A systematic review and analysis. J Psychiatr Pract 2016; 22: 84-98
41 de la Fuente-Tomas L, Sierra P, Sanchez-Autet M. et al. A clinical staging model for bipolar disorder: longitudinal approach. Transl Psychiatry 2020; 10: 45
42 Vieta E, Salagre E, Grande I. et al. Early intervention in bipolar disorder. Am J Psychiatry 2018; 175: 411-426
43 Davey CG, McGorry PD. Early intervention for depression in young people: A blind spot in mental health care. Lancet Psychiatry 2019; 6: 267-272
44 Zhang Z, Zhang L, Zhang G. et al. The effect of CBT and its modifications for relapse prevention in major depressive disorder: A systematic review and meta-analysis. BMC Psychiatry 2018; 18: 50
45 Lindner P, Hamilton W, Miloff A. et al. How to treat depression with low-intensity virtual reality Interventions: Perspectives on translating cognitive behavioral techniques into the virtual reality modality and how to make anti-depressive use of virtual reality-unique eExperiences. Front Psychiatry 2019; 10: 792
46 Fodor LA, Cotet CD, Cuijpers P. et al. The effectiveness of virtual reality based interventions for symptoms of anxiety and depression: A meta-analysis. Sci Rep 2018; 8: 10323
47 Jahn FS, Skovbye M, Obenhausen K. et al. Cognitive training with fully immersive virtual reality in patients with neurological and psychiatric disorders: A systematic review of randomized controlled trials. Psychiatry Res 2021; 300: 113928
48 Horlyck LD, Obenhausen K, Jansari A. et al. Virtual reality assessment of daily life executive functions in mood disorders: associations with neuropsychological and functional measures. J Affect Disord 2021; 280: 478-487
49 Pfennig A, Leopold K, Martini J. et al. Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: Study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife). Int J Bipolar Disord 2020; 8: 22
50 Ritter PS, Bermpohl F, Gruber O. et al. Aims and structure of the German Research Consortium BipoLife for the study of bipolar disorder. Int J Bipolar Disord 2016; 4: 26
51 Muhlbauer E, Bauer M, Ebner-Priemer U. et al. Effectiveness of smartphone-based ambulatory assessment (SBAA-BD) including a predicting system for upcoming episodes in the long-term treatment of patients with bipolar disorders: Study protocol for a randomized controlled single-blind trial. BMC Psychiatry 2018; 18: 349
52 Bauer M, Banaschewski T, Heinz A. et al. [The German research network for mental disorders]. Nervenarzt 2016; 87: 989-1010
53 Kircher T, Wohr M, Nenadic I. et al. Neurobiology of the major psychoses: A translational perspective on brain structure and function-the FOR2107 consortium. Eur Arch Psychiatry Clin Neurosci 2019; 269: 949-962